期刊
PHARMACOLOGICAL REPORTS
卷 61, 期 5, 页码 827-837出版社
POLISH ACAD SCIENCES INST PHARMACOLOGY
DOI: 10.1016/S1734-1140(09)70138-0
关键词
apoptosis; NMDA receptor; cerebellar neurons; caspase-3; MK-801; AP-5
资金
- Institute of Pharmacology Polish Academy of Sciences
Memantine, a NMDA receptor antagonist used in several experimental models of neuronal cell Injury, is a neuroprotective agent that can attenuate neuronal apoptosis connected with over-stimulation of NMDA receptors. In the present study, we evaluated the impact of memantine on apoptosis in primary cerebellar granule cell (CGC) cultures at 7 and 12 day in vitro (DIV) Cell death was induced by staurosporine (St, 0.5 mu M) or by decreasing the level of potassium in the culture medium (LP, 5 mM KCl) Both treatments induced cell death in CGC with higher cell-damaging effects at 12 DIV and 7 DIV neurons for St and LP, respectively - Memantine (0 1-2 mu M) partially attenuated St-induced apoptosis only in 7 DIV CGC as assessed by DNA fragmentation and LDH release, but not caspase-3 activity. During LP-induced apoptosis, memantine decreased LDH release and DNA fragmentation, bill not affected caspase-3 activity in 7 and 12 DIV CGC. Interestingly, we found no beneficial effects of other NMDA antagonists, including a competitive antagonist such as AP-5 (100 mu M) and an uncompetitive antagonist such as MK-801, (1 mu M). In conclusion, our data suggest that the anti-apoptotic effects of memantine in CGC are developmentally regulated and its neuroprotective action occurs through an NMDAR-independent mechanism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据